Literature DB >> 11393472

Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function.

E Lessard1, J Pouliot.   

Abstract

An anatomy-based dose optimization algorithm is developed to automatically and rapidly produce a highly conformal dose coverage of the target volume while minimizing urethra, bladder, and rectal doses in the delivery of an high dose-rate (HDR) brachytherapy boost for the treatment of prostate cancer. The dwell times are optimized using an inverse planning simulated annealing algorithm (IPSA) governed entirely from the anatomy extracted from a CT and by a dedicated objective function (cost function) reflecting clinical prescription and constraints. With this inverse planning approach, the focus is on the physician's prescription and constraint instead of on the technical limitations. Consequently, the physician's control on the treatment is improved. The capacity of this algorithm to represent the physician's prescription is presented for a clinical prostate case. The computation time (CPU) for IPSA optimization is less than 1 min (41 s for 142915 iterations) for a typical clinical case, allowing fast and practical dose optimization. The achievement of highly conformal dose coverage to the target volume opens the possibility to deliver a higher dose to the prostate without inducing overdosage of urethra and normal tissues surrounding the prostate. Moreover, using the same concept, it will be possible to deliver a boost dose to a delimited tumor volume within the prostate. Finally, this method can be easily extended to other anatomical sites.

Entities:  

Mesh:

Year:  2001        PMID: 11393472     DOI: 10.1118/1.1368127

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  35 in total

1.  Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot.

Authors:  J Adam Cunha; I-Chow Hsu; Jean Pouliot; Mack Roach Iii; Katsuto Shinohara; John Kurhanewicz; Galen Reed; Dan Stoianovici
Journal:  Minim Invasive Ther Allied Technol       Date:  2010-08       Impact factor: 2.442

2.  Optimization of light sources for prostate photodynamic therapy.

Authors:  Martin D Altschuler; Timothy C Zhu; Jun Li; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2005-04-22

3.  Fast dose optimization for rotating shield brachytherapy.

Authors:  Myung Cho; Xiaodong Wu; Hossein Dadkhah; Jirong Yi; Ryan T Flynn; Yusung Kim; Weiyu Xu
Journal:  Med Phys       Date:  2017-09-11       Impact factor: 4.071

4.  MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.

Authors:  Cynthia Ménard; Robert C Susil; Peter Choyke; Gary S Gustafson; William Kammerer; Holly Ning; Robert W Miller; Karen L Ullman; Nancy Sears Crouse; Sharon Smith; Etienne Lessard; Jean Pouliot; Victor Wright; Elliot McVeigh; C Norman Coleman; Kevin Camphausen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-08-01       Impact factor: 7.038

5.  Bi-objective optimization of catheter positions for high-dose-rate prostate brachytherapy.

Authors:  Marjolein C van der Meer; Peter A N Bosman; Yury Niatsetski; Tanja Alderliesten; Niek van Wieringen; Bradley R Pieters; Arjan Bel
Journal:  Med Phys       Date:  2020-10-21       Impact factor: 4.071

6.  Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.

Authors:  Martin D Altschuler; Timothy C Zhu; Jun Li; Stephen M Hahn
Journal:  Med Phys       Date:  2005-12       Impact factor: 4.071

7.  Comparison of manual and inverse optimisation techniques in high dose rate intracavitary brachytherapy of cervical cancer: A dosimetric study.

Authors:  Ram Abhinav Kannan; Janaki Manur Gururajachar; Arul Ponni; Kirthi Koushik; Mohan Kumar; Ram Charith Alva; Ritika Harjani; Arvind Murthy
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-26

8.  Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI.

Authors:  Yongbok Kim; I-Chow J Hsu; Etienne Lessard; John Kurhanewicz; Susan Moyher Noworolski; Jean Pouliot
Journal:  Radiother Oncol       Date:  2008-02-20       Impact factor: 6.280

9.  Does help structures play a role in reducing the variation of dwell time in IPSA planning for gynaecological brachytherapy application?

Authors:  Swamidas Jamema; Umesh Mahantshetty; Dd Deshpande; Smriti Sharma; Sk Shrivastava
Journal:  J Contemp Brachytherapy       Date:  2011-09-30

10.  On the feasibility of treating to a 1.5 cm PTV with a commercial single-entry hybrid applicator in APBI breast brachytherapy.

Authors:  Kent A Gifford; Christopher L Nelson; Steven M Kirsner; Kelly D Kisling; Matthew T Ballo; Elizabeth S Bloom
Journal:  J Contemp Brachytherapy       Date:  2012-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.